Public Employees Retirement Association of Colorado’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-26,016
Closed -$27K 1925
2024
Q3
$27K Buy
26,016
+9,682
+59% +$13.3K ﹤0.01% 1907
2024
Q2
$28K Sell
16,334
-311
-2% -$626 ﹤0.01% 1896
2024
Q1
$40K Sell
16,645
-9,197
-36% -$22.6K ﹤0.01% 1858
2023
Q4
$86K Hold
25,842
﹤0.01% 1800
2023
Q3
$97K Hold
25,842
﹤0.01% 1766
2023
Q2
$110K Hold
25,842
﹤0.01% 1781
2023
Q1
$177K Hold
25,842
﹤0.01% 1649
2022
Q4
$205K Hold
25,842
﹤0.01% 1585
2022
Q3
$248K Hold
25,842
﹤0.01% 1449
2022
Q2
$187K Hold
25,842
﹤0.01% 1645
2022
Q1
$334K Sell
25,842
-7,655
-23% -$97.3K ﹤0.01% 1420
2021
Q4
$535K Buy
+33,497
New +$586K ﹤0.01% 1183

Other funds holding CHRS

Public Employees Retirement Association of Colorado's CHRS Position: Q4 2024 in Review

Public Employees Retirement Association of Colorado sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 26,016 shares — an estimated $27K sold.

Public Employees Retirement Association of Colorado first reported a position in CHRS in Q4 2021 and held it in 12 quarters. The position peaked at $535K in Q4 2021. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • Public Employees Retirement Association of Colorado reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 26,016 Coherus Oncology shares in Q4 2024, an estimated $27K.
  • Public Employees Retirement Association of Colorado first reported a position in Coherus Oncology in Q4 2021 and held it in 12 quarters.
  • Public Employees Retirement Association of Colorado's Coherus Oncology position peaked at $535K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2024, filed 14 Feb 2025.